Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/17/08  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Fred Lowrey

Wrong Dr. Fred Lowrey?

Director-Clinical Affairs

Phone: (713) ***-****  HQ Phone
Pharm-Olam International Ltd
450 N. Sam Houston Parkway E. Suite 250
Houston , Texas 77060
United States

Company Description: Pharm-Olam International is one of the world's leading and fastest growing contract research organizations with employees and offices across the globe. Since 1994,...   more
Background

Employment History

Web References
Associate Advisory Board - BioHouston
www.biohouston.org, 17 Mar 2008 [cached]
Fred LowreyPharm-Olam International Ltd.
Management
www.endovasc.com, 3 April 2007 [cached]
Dr. Fred Lowrey,Clinical Research Consultant
Dr. Fred Lowrey, a pharmaceutical consultant, oversees the clinical and pre-clinical programs for Endovasc Inc.Dr. Lowrey brings over 20 years of drug development experience at major pharmaceutical and biotechnology companies, including Director of Clinical Operations for Zonagen and Chrysalis Biotechnology.
At present, Dr. Lowrey is Director of Clinical Affairs - The Americas, for Pharm-Olam International, a clinical research organization in Houston, Texas.
1july2002
www.pharmolam.co.uk, 1 July 2002 [cached]
Pharm-Olam Announces the addition of Dr. Fred Lowrey as Director, Clinical Affairs, the Americas and the hiring of Dr. Radhika Bobba as in-country manager for India.
...
Dr. Fred Lowrey was Director of Clinical Affairs for Chrysalis Biotechnology from 2000 to 2002 and Director of Clinical Operations for Zonagen, Inc. from 1990 to 2000.
Zonagen Receives IRB Approval to Commence Phase III Study of Androxal(TM) for the Treatment of Testosterone Deficiency: Financial News - Yahoo! Finance
biz.yahoo.com, 9 Jan 2006 [cached]
Cities where investigator sites are located include: Augusta, GA; Boston, MA; Carmichael, CA; Columbia, SC; Ft. Lauderdale, FL; Huntsville, AL; Mission Viejo, CA; Nashville, TN; Ocala, FL; Oklahoma City, OK; Salt Lake City, UT; San Diego, CA; Tacoma, WA; and Tallahassee, FL. Patients interested in participating in the study should contact Dr. Fred Lowrey, Director of Clinical Affairs for POI, or Jocelyn Kerr, Project Manager for the study at 713-463-8075.
Pharm-Olam International - POI Focus
www.pharm-olam.com, 11 July 2004 [cached]
Fred Lowrey DVM, MS, Director of Clinical Affairs in the Americas, oversees the early-phase development group and has been conducting pre-clinical and phase I/II studies for over 20 years.For more information on POI's early-phase development program, please contact Dr. Lowrey at 713-463-8075 or flowrey@pharm-olam.com.
Other People with the name "Lowrey":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304